research BH15 Efficacy and safety of baricitinib in the management of severe alopecia areata over a 6-month period: a real-world experience
Baricitinib was effective and safe for severe hair loss treatment over 6 months.
Search
for
Sort by
Research
990-1000 / 1000+ results 
research Chronic Exposure of 5‐Alpha Reductase Inhibitor in Young Male Rats Induces Not Only Metabolic Disturbance, But Also Depressive‐Like Behaviors as Similar with Obese Condition
Long-term use of a drug for hair loss and prostate issues can cause metabolic problems and depression-like behavior in young male rats.
research COPD at the end of life: Predictors of the emotional distress of patients and their family caregivers
Caregiver burden and patient health issues significantly affect emotional distress in both COPD patients and their caregivers.
research Investigating the interplay of social defeat stress and personality in male and female zebrafish
Personality affects stress response more than social rank in zebrafish.
research Assessment of quality of life and self‐esteem in male patients with androgenetic alopecia before and after hair transplantation
Hair transplantation significantly improves quality of life and self-esteem in men with hair loss.
research Newborn screening for biotinidase deficiency: pilot study and follow-up of identified cases
Newborn screening for biotinidase deficiency is effective in preventing severe complications.
research Limitations of Treatment-Induced Alopecia Grading Instruments in Evaluating Therapeutic Response
Current methods for grading hair loss from cancer treatment are not accurate enough and need improvement.
research Beyond hair loss: Exploring the psychiatric burden of alopecia areata in a large cohort
Alopecia areata patients often face mental health issues like anxiety and depression.
research Finasteride-related self-harm and suicidal ideation
research Supplementary Material for: Patient Preferences: Results of a German Adaptive Choice-Based Conjoint Analysis (Market Research Study Sponsored by Eli Lilly and Company) in Patients on Palliative Treatment for Advanced Breast Cancer
Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.